US Stock MarketDetailed Quotes

Infinity Pharmaceuticals (INFI)

Watchlist

0.008
0.0000.00%

15min DelayClose Oct 3 16:00 ET

726.09KMarket Cap-0.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Infinity Pharmaceuticals (INFI) Income Statement

Quarterly·All

YOY

Hide blank lines

Currency: USD

2023/Q2

2023/Q1

2022/Q4

2022/Q3

2022/Q2

2022/Q1

2021/Q4

2021/Q3

2021/Q2

2021/Q1

2020/Q4

2020/Q3

2020/Q2

2020/Q1

2019/Q4

2019/Q3

2019/Q2

2019/Q1

2018/Q4

2018/Q3

Total Revenue as Reported

-15.01%583.00K

+12.12%731.00K

+20.40%543.00K

+66.36%712.00K

+33.98%686.00K

+39.61%652.00K

+3.44%451.00K

-13.71%428.00K

+42.22%512.00K

+9.11%467.00K

+41.56%436.00K

+44.61%496.00K

+40.08%360.00K

-80.02%428.00K

+110.96%308.00K

-98.44%343.00K

--257.00K

--2.14M

--146.00K

+266.67%22.00M

Total Operating Revenue

-15.01%583.00K

+12.12%731.00K

+20.40%543.00K

+66.36%712.00K

+33.98%686.00K

+39.61%652.00K

+3.44%451.00K

-13.71%428.00K

+42.22%512.00K

+9.11%467.00K

+41.56%436.00K

+44.61%496.00K

+40.08%360.00K

-80.02%428.00K

+110.96%308.00K

-98.44%343.00K

--257.00K

--2.14M

--146.00K

+266.67%22.00M

Cost of Revenue

-14.98%352.00K

+12.21%441.00K

+20.22%327.00K

+66.28%429.00K

+34.42%414.00K

+39.36%393.00K

+3.42%272.00K

-13.71%258.00K

+41.94%308.00K

+9.30%282.00K

+42.16%263.00K

+44.44%299.00K

+40.00%217.00K

-96.18%258.00K

+168.12%185.00K

--207.00K

--155.00K

--6.76M

--69.00K

--0.00

Gross Profit

-15.07%231.00K

+11.97%290.00K

+20.67%216.00K

+66.47%283.00K

+33.33%272.00K

+40.00%259.00K

+3.47%179.00K

-13.71%170.00K

+42.66%204.00K

+8.82%185.00K

+40.65%173.00K

+44.85%197.00K

+40.20%143.00K

+103.68%170.00K

+59.74%123.00K

-99.38%136.00K

--102.00K

---4.62M

--77.00K

--22.00M

Operating Expense

-15.78%10.35M

-6.86%11.80M

-16.48%9.75M

+2.23%11.16M

+7.29%12.29M

+7.64%12.67M

+12.23%11.68M

+20.77%10.92M

+26.41%11.46M

+10.28%11.77M

-10.88%10.41M

-15.63%9.04M

-7.97%9.06M

+16.43%10.67M

+36.86%11.68M

+21.49%10.72M

+38.01%9.85M

-3.71%9.16M

+6.38%8.53M

-36.28%8.82M

Selling and Admin Expenses

+7.41%3.75M

+61.70%5.94M

-14.47%2.79M

-8.99%3.50M

-0.09%3.50M

+3.08%3.68M

+1.12%3.26M

+31.30%3.85M

+19.10%3.50M

+7.28%3.57M

-7.24%3.23M

-19.53%2.93M

-22.12%2.94M

-2.18%3.32M

-8.76%3.48M

+5.78%3.64M

+11.37%3.77M

-5.77%3.40M

-14.66%3.81M

-23.60%3.44M

-General & Admin Expense

+7.41%3.75M

+61.70%5.94M

-14.47%2.79M

-8.99%3.50M

-0.09%3.50M

+3.08%3.68M

+1.12%3.26M

+31.30%3.85M

+19.10%3.50M

+7.28%3.57M

-7.24%3.23M

-19.53%2.93M

-22.12%2.94M

-2.18%3.32M

-8.76%3.48M

+5.78%3.64M

+11.37%3.77M

-5.77%3.40M

-14.66%3.81M

-23.60%3.44M

Research & Development

-24.99%6.60M

-34.89%5.85M

-17.26%6.96M

+8.34%7.66M

+10.53%8.80M

+9.62%8.99M

+17.23%8.42M

+15.72%7.07M

+29.91%7.96M

+11.64%8.20M

-12.43%7.18M

-13.62%6.11M

+0.81%6.13M

+27.40%7.35M

+73.72%8.20M

+31.55%7.08M

+62.07%6.08M

-2.45%5.77M

+32.85%4.72M

-42.40%5.38M

Operating Profit

+15.79%-10.12M

+7.25%-11.51M

+17.06%-9.54M

-1.22%-10.88M

-6.82%-12.02M

-7.12%-12.41M

-12.38%-11.50M

-21.54%-10.75M

-26.15%-11.25M

-10.30%-11.58M

+11.43%-10.23M

+16.41%-8.85M

+8.48%-8.92M

+23.82%-10.50M

-36.65%-11.55M

-180.29%-10.58M

-36.58%-9.75M

-44.83%-13.78M

-5.42%-8.46M

+268.04%13.18M

Net Non-Operating Interest Income (Expense)

+0.00%-45.00K

+93.00%-45.00K

+92.81%-45.00K

+92.55%-45.00K

+92.13%-45.00K

-1592.11%-643.00K

+44.85%-626.00K

+44.43%-604.00K

-88.16%-572.00K

---38.00K

---1.14M

---1.09M

-226.88%-304.00K

+100.00%0.00

Non-Operating Interest Expense

+0.00%45.00K

-93.00%45.00K

-92.81%45.00K

-92.55%45.00K

-92.13%45.00K

+1592.11%643.00K

-44.85%626.00K

-44.43%604.00K

+88.16%572.00K

--38.00K

--1.14M

--1.09M

+226.88%304.00K

-100.00%0.00

Other Income (Expense)

+171.43%209.00K

+3068.75%507.00K

+433.02%353.00K

+154.88%209.00K

+185.19%77.00K

+900.00%16.00K

-138.27%-106.00K

+230.16%82.00K

-46.00%27.00K

-101.08%-2.00K

+31.90%277.00K

-121.07%-63.00K

-84.28%50.00K

-35.64%186.00K

-10.64%210.00K

+48.02%299.00K

+84.88%318.00K

+81.76%289.00K

+89.52%235.00K

-80.31%202.00K

Gain on Sale of Security

+171.43%209.00K

+3068.75%507.00K

+433.02%353.00K

+154.88%209.00K

+185.19%77.00K

+900.00%16.00K

-138.27%-106.00K

+230.16%82.00K

-46.00%27.00K

-101.08%-2.00K

+31.90%277.00K

-121.07%-63.00K

-84.28%50.00K

-35.64%186.00K

-10.64%210.00K

+48.02%299.00K

+84.88%318.00K

+81.76%289.00K

+89.52%235.00K

-80.31%202.00K

Pretax Profit

+16.94%-9.96M

+11.19%-11.05M

+20.78%-9.23M

-0.04%-10.72M

-6.36%-11.99M

-6.94%-12.44M

-9.93%-11.65M

-12.37%-10.71M

-18.96%-11.27M

-6.83%-11.63M

+6.88%-10.60M

+16.49%-9.53M

+9.90%-9.47M

+21.10%-10.89M

-38.47%-11.38M

-185.32%-11.42M

-51.00%-10.51M

-46.00%-13.80M

-2.54%-8.22M

+288.36%13.38M

Tax

----

--0.00

---54.00K

--0.00

Net Profit

+16.94%-9.96M

+11.19%-11.05M

+20.78%-9.23M

-0.04%-10.72M

-6.36%-11.99M

-6.94%-12.44M

-9.93%-11.65M

-12.37%-10.71M

-18.96%-11.27M

-6.83%-11.63M

+6.88%-10.60M

+16.49%-9.53M

+9.90%-9.47M

+20.79%-10.89M

-38.47%-11.38M

-185.32%-11.42M

-51.00%-10.51M

-45.42%-13.74M

-12.66%-8.22M

+288.36%13.38M

Profit from Continuing Operations

+16.94%-9.96M

+11.19%-11.05M

+20.78%-9.23M

-0.04%-10.72M

-6.36%-11.99M

-6.94%-12.44M

-9.93%-11.65M

-12.37%-10.71M

-18.96%-11.27M

-6.83%-11.63M

+6.88%-10.60M

+16.49%-9.53M

+9.90%-9.47M

+20.79%-10.89M

-38.47%-11.38M

-185.32%-11.42M

-51.00%-10.51M

-45.42%-13.74M

-12.66%-8.22M

+288.36%13.38M

Net Income to Parent Company

+16.94%-9.96M

+11.19%-11.05M

+20.78%-9.23M

-0.04%-10.72M

-6.36%-11.99M

-6.94%-12.44M

-9.93%-11.65M

-12.37%-10.71M

-18.96%-11.27M

-6.83%-11.63M

+6.88%-10.60M

+16.49%-9.53M

+9.90%-9.47M

+20.79%-10.89M

-38.47%-11.38M

-185.32%-11.42M

-51.00%-10.51M

-45.42%-13.74M

-12.66%-8.22M

+288.36%13.38M

Net Income to Common Stockholders

+16.94%-9.96M

+11.19%-11.05M

+20.78%-9.23M

-0.04%-10.72M

-6.36%-11.99M

-6.94%-12.44M

-9.93%-11.65M

-12.37%-10.71M

-18.96%-11.27M

-6.83%-11.63M

+6.88%-10.60M

+16.49%-9.53M

+9.90%-9.47M

+20.79%-10.89M

-38.47%-11.38M

-185.32%-11.42M

-51.00%-10.51M

-45.42%-13.74M

-12.66%-8.22M

+288.36%13.38M

Basic EPS

+15.38%-0.11

+14.29%-0.12

+15.38%-0.11

+0.00%-0.12

+0.00%-0.13

+6.67%-0.14

+23.53%-0.13

+25.00%-0.12

+18.75%-0.13

+21.05%-0.15

+15.00%-0.17

+20.00%-0.16

+11.11%-0.16

+20.83%-0.19

-42.86%-0.20

-186.96%-0.20

-50.00%-0.18

-33.33%-0.24

+0.00%-0.14

+264.29%0.23

Diluted EPS

+15.38%-0.11

+14.29%-0.12

+15.38%-0.11

+0.00%-0.12

+0.00%-0.13

+6.67%-0.14

+23.53%-0.13

+25.00%-0.12

+18.75%-0.13

+21.05%-0.15

+15.00%-0.17

+20.00%-0.16

+11.11%-0.16

+20.83%-0.19

-42.86%-0.20

-186.96%-0.20

-50.00%-0.18

-33.33%-0.24

+0.00%-0.14

+264.29%0.23

Deadline

Jun 30, 2023

Mar 31, 2023

Dec 31, 2022

Sep 30, 2022

Jun 30, 2022

Mar 31, 2022

Dec 31, 2021

Sep 30, 2021

Jun 30, 2021

Mar 31, 2021

Dec 31, 2020

Sep 30, 2020

Jun 30, 2020

Mar 31, 2020

Dec 31, 2019

Sep 30, 2019

Jun 30, 2019

Mar 31, 2019

Dec 31, 2018

Sep 30, 2018

Accounting Standard

US_GAAP

	2023/Q2	2023/Q1	2022/Q4	2022/Q3	2022/Q2	2022/Q1	2021/Q4	2021/Q3	2021/Q2	2021/Q1	2020/Q4	2020/Q3	2020/Q2	2020/Q1	2019/Q4	2019/Q3	2019/Q2	2019/Q1	2018/Q4	2018/Q3

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm